Results for tag: "Pharmaceutical Aerosol"

The Pharmaceutical Aerosol market is composed of inhalers and nebulisers, which are used to deliver medication to the lungs. Inhalers are devices that deliver medication in the form of a mist or spray, which is then inhaled by the patient. Nebulisers are devices that convert liquid medication into a fine mist, which is then inhaled by the patient. Both inhalers and nebulisers are used to treat a variety of respiratory conditions, such as asthma, COPD, and cystic fibrosis. Inhalers are typically divided into two categories: pressurised metered dose inhalers (pMDIs) and dry powder inhalers (DPIs). pMDIs are the most commonly used inhalers, and they deliver medication in the form of a pressurised aerosol. DPIs are devices that deliver medication in the form of a dry powder, which is then inhaled by the patient. Nebulisers are devices that convert liquid medication into a fine mist, which is then inhaled by the patient. Nebulisers are typically used to deliver medication to patients who are unable to use inhalers, such as young children or elderly patients. Some of the companies in the Pharmaceutical Aerosol market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, Merck, and Teva Pharmaceuticals. Show Less Read more